Trial gives thumbs up to Winx
REDWOOD CITY, Calif. – ApniCure has announced that positive results from the ATLAST clinical trials of its Winx sleep therapy system to treat obstructive sleep apnea have been published in Sleep Medicine. The trial results show significant improvements in both apnea-hypopnea index (AHI) and oxygen desaturation index (ODI) on the first night of treatment and following 28 days of using the Winx. The results also show high levels of patient adherence, and improvements in sleep architecture and subjective sleepiness. The Winx uses a soft, flexible mouthpiece and slim tubing, allowing sleeping in any position. It received clearance from the U.S. Food and Drug Administration (FDA) in March 2012.